BioMarin Pharmaceutical Inc.

BMRN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$943$755$725$587
Short-Term Investments$195$319$567$427
Receivables$661$634$461$373
Inventory$1,233$1,107$894$777
Other Curr. Assets$202$141$105$110
Total Curr. Assets$3,232$2,956$2,751$2,274
Property Plant & Equip (Net)$1,043$1,066$1,073$1,035
Goodwill$196$196$196$196
Intangibles$255$295$339$389
Long-Term Investments$521$611$334$508
Tax Assets$1,489$1,546$1,505$1,450
Other NC Assets$251$172$176$152
Total NC Assets$3,757$3,886$3,624$3,730
Other Assets$0$0$0$0
Total Assets$6,989$6,842$6,375$6,005
Liabilities
Payables$235$316$231$200
Short-Term Debt$23$503$10$10
Tax Payable$13$3$16$1
Deferred Revenue$1$5$1$7
Other Curr. Liab.$335$352$330$328
Total Curr. Liab.$607$1,177$589$546
LT Debt$626$593$1,083$1,079
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$98$120$100$114
Total NC Liab.$724$713$1,183$1,193
Other Liabilities$0$0$0$0
Cap. Leases$31$9$10$10
Total Liabilities$1,331$1,890$1,772$1,739
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$195-$622-$789-$931
AOCI$62-$29-$4$14
Other Equity$5,791$5,602$5,396$5,182
Total Equity$5,658$4,952$4,603$4,266
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,989$6,842$6,375$6,005
Net Debt-$293$341$369$502